Clinical Trial Update: The Nutritional Supplement Phosphatidylserine in Patients With Familial Dysautonomia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing phosphatidylserine in patients with familial dysautonomia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Dysautonomia

Drugs mentioned

• Phosphatidylserine (phosphatidylserine)

Snippet

Sponsor: NYU Langone Health | Conditions: Familial Dysautonomia | Phase 2 | Status: COMPLETED